Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-18 4:49 pm Unchanged | 2025-12-31 | 13G | DERMATA THERAPEUTICS INC P DRMA | ARMISTICE CAPITAL LLC | 53,910 4.990% | 0 (Unchanged) | Filing History |
| 2026-02-18 4:48 pm Unchanged | 2025-12-31 | 13G | BLUEJAY DIAGNOSTICS INC PA BJDX | ARMISTICE CAPITAL LLC | 194,132 9.990% | 0 (Unchanged) | Filing History |
| 2026-02-18 4:47 pm Purchase | 2025-12-31 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | ARMISTICE CAPITAL LLC | 3,236,000 6.480% | 951,619 (+41.66%) | Filing History |
| 2026-02-18 4:46 pm Sale | 2025-12-31 | 13G | ALTO NEUROSCIENCE INC ANRO | ARMISTICE CAPITAL LLC | 1,536,000 4.940% | -88,000 (-5.42%) | Filing History |
| 2026-02-18 11:15 am Sale | 2025-12-31 | 13G | VOYAGER THERAPEUTICS INC VYGR | ARMISTICE CAPITAL LLC | 4,000,000 7.190% | -200,000 (-4.76%) | Filing History |
| 2026-02-18 11:06 am Purchase | 2025-12-31 | 13G | ADIAL PHARMACEUTICALS INC ADIL | ARMISTICE CAPITAL LLC | 2,799,643 9.990% | 2,786,191 (+20712.09%) | Filing History |
| 2026-02-17 9:55 pm Purchase | 2025-12-31 | 13G | CYCURION, INC CYCU | ARMISTICE CAPITAL LLC | 301,052 9.990% | 301,052 (New Position) | Filing History |
| 2026-02-17 9:55 pm Purchase | 2025-12-31 | 13G | BLUEJAY DIAGNOSTICS INC PA BJDX | ARMISTICE CAPITAL LLC | 194,132 9.990% | 192,394 (+11069.85%) | Filing History |
| 2026-02-17 9:55 pm Purchase | 2025-12-31 | 13G | BIODEXA PHARMACEUTICALS INC SP BDRX | ARMISTICE CAPITAL LLC | 56,700 9.990% | 56,680 (+283400.00%) | Filing History |
| 2026-02-17 9:54 pm Purchase | 2025-12-31 | 13G | ASCENT SOLAR TECHNOLOGIES INC ASTI | ARMISTICE CAPITAL LLC | 386,142 9.990% | 386,142 (New Position) | Filing History |
| 2026-02-17 9:54 pm Purchase | 2025-12-31 | 13G | AGIOS PHARMACEUTICALS INC AGIO | ARMISTICE CAPITAL LLC | 3,036,000 5.210% | 828,930 (+37.56%) | Filing History |
| 2026-02-17 9:54 pm Sale | 2025-12-31 | 13G | AETHLON MED INC PAR $0.001 AEMD | ARMISTICE CAPITAL LLC | 84,496 9.990% | -51,990 (-38.09%) | Filing History |
| 2026-02-17 9:53 pm Purchase | 2025-12-31 | 13G | ACTELIS NETWORKS INC PAR $ ASNS | ARMISTICE CAPITAL LLC | 917,950 4.990% | 827,790 (+918.13%) | Filing History |
| 2026-02-17 9:53 pm Unchanged | 2025-12-31 | 13G | ANGIODYNAMICS INC ANGO | ARMISTICE CAPITAL LLC | 1,624,000 6.000% | 0 (Unchanged) | Filing History |
| 2026-02-17 9:52 pm Purchase | 2025-12-31 | 13G | CITIUS ONCOLOGY INC CTOR | ARMISTICE CAPITAL LLC | 8,078,404 9.990% | 402,493 (+5.24%) | Filing History |
| 2026-02-17 9:52 pm Purchase | 2025-12-31 | 13G | CURIS INC PAR $0.01 CRIS | ARMISTICE CAPITAL LLC | 1,336,876 9.990% | 49,539 (+3.85%) | Filing History |
| 2026-02-17 9:52 pm Purchase | 2025-12-31 | 13G | AVANOS MEDICAL INC AVNS | ARMISTICE CAPITAL LLC | 3,200,000 6.890% | 700,000 (+28.00%) | Filing History |
| 2026-02-17 9:51 pm Purchase | 2025-12-31 | 13G | AUTOLUS THERAPEUTICS PLC SPONS AUTL | ARMISTICE CAPITAL LLC | 17,500,000 6.580% | 1,900,000 (+12.18%) | Filing History |
| 2026-02-17 9:51 pm Purchase | 2025-12-31 | 13G | ARIDIS PHARMACEUTICALS INC ARDS | ARMISTICE CAPITAL LLC | 5,096,251 11.430% | 3,583,807 (+236.95%) | Filing History |
| 2026-02-17 9:50 pm Purchase | 2025-12-31 | 13G | INVO FERTILITY INC PAR $0. IVF | ARMISTICE CAPITAL LLC | 120,593 9.990% | 120,593 (New Position) | Filing History |